SCHEMBL8312307

SCHEMBL8312307

CC(=O)c1ccc(SCCCO)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.55
HPGD P15428 3/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
LMNA P02545 1/20 0.53
CA2 P00918 4/20 0.53
ALDH1A1 P00352 3/20 0.47
GAA P10253 1/20 0.46
MAPT P10636 4/20 0.44
KMT2A Q03164 1/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 2/20 0.43
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA7 P43166 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4065222 0.95 CA2 (0.54) HRH3HPGDL3MBTL1LMNACA2
SCHEMBL10872171 0.89 HPGD (0.57) HRH3HPGDL3MBTL1LMNACA2
SCHEMBL10498096 0.85 HRH3 (0.55) HRH3HPGDL3MBTL1LMNAALDH1A1
SCHEMBL6272928 0.84 THRB (0.60) HRH3HPGDL3MBTL1LMNAALDH1A1
SCHEMBL1018124 0.83 CA2 (0.54) CA2ALDH1A1RAB9ANPC1THRA
SCHEMBL3964843 0.82 THRB (0.62) HRH3HPGDL3MBTL1LMNAALDH1A1
SCHEMBL11440830 0.82 THRB (0.62) HRH3HPGDL3MBTL1LMNAALDH1A1
SCHEMBL10884297 0.82 THRB (0.62) HRH3HPGDL3MBTL1LMNAALDH1A1
SCHEMBL11434515 0.82 THRB (0.62) HRH3HPGDL3MBTL1LMNAALDH1A1
SCHEMBL2213968 0.82 ALDH1A1 (0.66) HRH3HPGDL3MBTL1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1349841-B1 ANILINOPYRIMIDINE DERIVATIVES AS IKK INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARM LLC (US) 2009-12-02 EP disclosed
EP-1349840-B1 ANILINOPYRIMIDINE DERIVATIVES AS JNK PATHWAY INHIBITORS AND COMPOSITIONS AND METHODS RELATED THERETO SIGNAL PHARM LLC (US) 2009-03-11 EP disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed